Please use this identifier to cite or link to this item:
|Title:||FATE: the new partnership to Fight Against TB in Central and Eastern Europe||Authors:||Jagielski, Tomasz
Osmani, Gjyle Mulliqi
van Ingen, Jakko
Yablonsky, Peter K.
Mokrousov, Igor V.
|Issue Date:||Apr-2017||Publisher:||Elsevier||Journal:||Lancet Infectious Diseases||Abstract:||Central and eastern Europe is a hotspot for drug-resistant tuberculosis and most countries in the region face similar threats (figure, appendix) and opportunities, including the introduction of molecular tests for rapid diagnosis of drug-resistant tuberculosis. Yet, regional collaboration and a single recognisable organisation that could act as an interface with other relevant parties, such as the WHO, European Centre for Disease Prevention and Control, non-governmental organisations (NGOs), funding agencies, and scientific consortia, are still lacking. To improve this situation, most relevant tuberculosis authorities in the region, including the national reference laboratories, have set up the Partnership to Fight Against TB in Central and Eastern Europe (FATE).||URI:||https://cris.pasteurorg.ru/handle/123456789/67||ISSN:||14733099||DOI:||10.1016/S1473-3099(17)30120-2|
|Appears in Collections:||Journal articles|
Show full item record
checked on Apr 17, 2019
checked on Apr 20, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.